CMVictory Study

Project Plan

We are looking for healthy women (aged 16 to 17 years) to take part in an important study aiming to help protect babies from life-threatening birth defects caused by cytomegalovirus (CMV).

  • CMV is a common viral infection that can be very dangerous in pregnancy and lead to babies being born with severe, life-long disabilities and hearing loss.
  • It is one of the leading causes of birth defects yet there is currently no vaccine available to protect against CMV.
  • Researchers are evaluating the safety and effectiveness of an investigational CMV vaccine that may prevent future generations from contracting the virus.

Your Support

Healthy women aged 16 to 17 years are invited to take part!

Potential participants initially attend a screening visit to determine eligibility. If eligible, participants would be involved for around 2.5 years with 14 visits to PCH over this time. Participants will be randomly assigned to receive the investigational vaccine or a placebo. Blood tests and urine samples will also be taken at various time points. Data collected will inform future research and get us closer to a vaccine to protect Mum’s and their bubs!

For more information or to get involved:

Read additional information about the study on the Telethon Kids Institute website.

Please contact the study staff at the Vaccine Trials Group – part of the Wesfarmers Centre of Vaccines and Infectious Diseases based at Telethon Kids Institute:

This trial has been approved by the ethics committee at Monash Health.

Project Members

Dr Ushma Wadia
Principal Investigator
Heidi Hutton
Study Coordinator